Dr. Barry Dworkin

Disease-modifying drug reduces brain protein plaques in Alzheimer patients

Madely Health Headlines Commentary for March 1, 2010

Source:

Neuroimaging technique shows potential of bapineuzumab treatment and might be useful in assessing other drugs for Alzheimer’s Disease

Reference:

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer’s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Related posts:

  1. Basic science research trying to unravel the mechanism of Alzheimer's disease
  2. New cell treatment may help treat MS and Cerebral Palsy
  3. Chip technology may help monitor cancer treatment success
  4. Genetic switch discovered that may help in development in treatment of stroke, heart disease, and cancer among others

Leave a Reply